Clinical trials
Phase 1 Atrial Fibrillation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 6 |
| Recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| GlaxoSmithKline | 2 |
| University of Oklahoma | 2 |
| C. R. Bard | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| Northwell Health | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Thryv Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 21 |
| Arrhythmias, Cardiac | 1 |
| COVID-19 | 1 |
| Heart Failure | 1 |
| Heart Valve Diseases | 1 |
| Neoplasms | 1 |
| Obesity | 1 |
| Postoperative Complications | 1 |
| Stroke | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.